Related Experiment Video
Updated: Jul 20, 2026

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
Published on: April 11, 2025
Progressive severe visual loss after long-term withdrawal from thioridazine treatment
I A Chaudhry1, F A Shamsi, M L Weitzman
1Oculoplastic and Orbit Division, King Khaled Eye Specialist Hospital, PO Box 7191, Riyadh 11462, Kingdom of Saudi Arabia. orbitdr@hotmail.com
Long-term thioridazine (a medication) can cause progressive vision loss years after stopping treatment. This retinopathy may lead to severe sight impairment, even with normal-appearing optic nerves.
Area of Science:
- Ophthalmology
- Toxicology
Background:
- Thioridazine is an antipsychotic medication with known ocular side effects.
- Chronic use has been linked to retinal toxicity.
Observation:
- A 50-year-old woman presented with progressive vision loss over 30 years post-thioridazine cessation.
- Fundus examination showed retinal pigment epithelium (RPE) clumping and generalized RPE/choroidal atrophy.
Findings:
- Despite severe vision loss (no light perception), optic nerves and retinal vasculature appeared relatively normal.
- Advanced thioridazine retinopathy can manifest with delayed, progressive visual decline.
Implications:
- This case highlights the potential for long-term, irreversible vision loss from thioridazine.
- Ophthalmologists should consider medication history in patients with unexplained progressive vision loss.
- Monitoring for delayed ocular toxicity is crucial in patients with a history of thioridazine use.
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Psychosis: Goals of Pharmacotherapy
Diabetic Retinopathy
